We are live on ! Find out more
RG

Redmile Group Portfolio holdings

AUM $1.49B Turnover 10.26%
1-Year Est. Return 208.7%
This Fund
S&P 500
This Quarter Est. Return
-13.94%
1 Year Est. Return
+208.7%
3 Year Est. Return
+777.5%
5 Year Est. Return
+1,114.43%
10 Year Est. Return
+23,630.52%
AUM
$2.49B
AUM Growth
-$764M
Cap. Flow
-$255M
Cap. Flow %
-10.24%
Top 10 Hldgs %
45.62%
Holding
96
New
13
Increased
17
Reduced
38
Closed
17
Avg Time Held
1.2 years
Top 10 Avg Time Held
1.2 years
Top 20 Avg Time Held
1.2 years

Top Buys

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$46.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$45.9M
3
MDT icon
Medtronic
MDT
+$39.2M
4
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$37.5M
5
EPZM
Epizyme, Inc
EPZM
+$33.5M

Top Sells

Rank Stock Value
1
WCG
Wellcare Health Plans, Inc.
WCG
+$50M
2
BLUE icon
bluebird bio
BLUE
+$36.8M
3
ELV icon
Elevance Health
ELV
+$32.6M
4
CNC icon
Centene
CNC
+$32.1M
5
NUVA
NuVasive, Inc.
NUVA
+$31.2M

Sector Composition

Rank Sector Weight
1 Healthcare 96.57%
2 Miscellaneous 1.72%
3 Financials 1.69%
4 Energy 0.02%
5 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CSLT
76
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$22K ﹤0.01%
10,229
– –
2018 Q2
2 quarters
A icon
77
Agilent Technologies
A
$49.6B
– –
-306,400
Closed -$21.6M –
AMED icon
78
DELISTED
Amedisys
AMED
– –
-2,725
Closed -$341K –
BLUE icon
79
DELISTED
bluebird bio
BLUE
– –
-19,462
Closed -$36.8M –
CNC icon
80
Centene
CNC
$35B
– –
-443,490
Closed -$32.1M –
ELAN icon
81
Elanco Animal Health
ELAN
$11.8B
– –
-525,000
Closed -$18.3M –
HRTX icon
82
Heron Therapeutics
HRTX
$71.2M
– –
-10,850
Closed -$343K –
IHF icon
83
iShares US Healthcare Providers ETF
IHF
$1.44B
– –
-10,435
Closed -$417K –
PRQR icon
84
ProQR Therapeutics
PRQR
$206M
– –
-1,450,925
Closed -$28.1M –
SENS icon
85
Senseonics Holdings Inc
SENS
$431M
– –
-2,245
Closed -$214K –
SGRY icon
86
Surgery Partners
SGRY
$1.94B
– –
-634,400
Closed -$10.5M –
STIM icon
87
Neuronetics
STIM
$148M
– –
-180,999
Closed -$5.8M –
VJET
88
Flyte Aviation, Inc.
VJET
$1.94M
– –
0
– -$1.55M
2018 Q3
1 quarter
ZTS icon
89
Zoetis
ZTS
$32.6B
– –
-253,300
Closed -$23.2M –
CTLT icon
90
DELISTED
CATALENT, INC.
CTLT
– –
-668,850
Closed -$30.5M –
SYNH
91
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-428,473
Closed -$22.1M –
NUVA
92
DELISTED
NuVasive, Inc.
NUVA
– –
-439,700
Closed -$31.2M –
IIN
93
DELISTED
IntriCon Corporation
IIN
– –
-125,000
Closed -$7.03M –
WCG
94
DELISTED
Wellcare Health Plans, Inc.
WCG
– –
-155,909
Closed -$50M –
1 2 3
4

Similar funds

FCM
Fairholme Capital Management South Miami, Florida $1.49B AUM 28.35% 1-Year Est. Return
MM
Main Management San Francisco, California $1.49B AUM 22.28% 1-Year Est. Return
WA
WBH Advisory Baltimore, Maryland $1.49B AUM 20.41% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.49B AUM 32.81% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
GAM
Gemmer Asset Management Walnut Creek, California $1.49B AUM 42.66% 1-Year Est. Return
MFWP
Mosaic Family Wealth Partners St. Louis, Missouri $1.49B AUM 26.43% 1-Year Est. Return
PMG
ProVise Management Group Clearwater, Florida $1.49B AUM 21.79% 1-Year Est. Return

Redmile Group's Q4 2018 Portfolio in Review

As of Q4 2018, Redmile Group held 96 positions worth $2.49B, down 24% from $3.25B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Redmile Group withdrew a net $255M in Q4 2018, closing 17 positions and reducing 38 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $50M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 96% a quarter earlier, followed by Miscellaneous and Financials.

Against the trend, Redmile Group opened a new position in Bristol-Myers Squibb worth $44.4M.

  • Redmile Group's largest Q4 2018 buy was Bristol-Myers Squibb: 854,700 shares worth $44.4M.
  • Redmile Group added most to Clovis Oncology, Inc. in Q4 2018, an estimated $46.6M increase.
  • Redmile Group's biggest Q4 2018 reduction was Elevance Health, cutting an estimated $32.6M.
  • Redmile Group fully exited Wellcare Health Plans, Inc. in Q4 2018, selling an estimated $50M.
  • Redmile Group's ten largest holdings make up 46% of its $2.49B portfolio in Q4 2018.
  • Redmile Group opened 13 new positions and closed 17 in Q4 2018.
  • Redmile Group's portfolio value fell 24% quarter-over-quarter to $2.49B.

Based on Redmile Group's 13F filing for Q4 2018, filed 14 Feb 2019.